NCT03706274View on ClinicalTrials.gov

PROCLAIM-CX-188: A Trial to Find Safe and Active Doses of an Investigational Drug CX-188 for Patients With Solid Tumors

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2022

Conditions
Solid Tumor, Adult
Interventions
DRUG

CX-188

CX-188

Trial Locations (1)

22031

Virginia Cancer Specialists, Fairfax

Sponsors
All Listed Sponsors
lead

CytomX Therapeutics

INDUSTRY

NCT03706274 - PROCLAIM-CX-188: A Trial to Find Safe and Active Doses of an Investigational Drug CX-188 for Patients With Solid Tumors | Biotech Hunter | Biotech Hunter